ARCHIVES

FDA Approves Xeloda For Colon Cancer; Phase III Data Not Reviewed By ODAC.

This article is from The Cancer Letter archive.

Vol. 27 No. 18 | May 4, 2001

Download PDF Visit The Full Archive

Related Articles

“Whatever Happened To…?” ACS Follows Up Five Years Later

August 26, 1977

Central Line Safety Intervention Lowers Patient Infection Rate

October 25, 2013

An Angel In heaven – Or How Rejected Grants Do and Don’t Get Reviewed

May 3, 1974

FDA News: Clinton Nominates Jane Henney For FDA Commissioner

June 26, 1998

NCI To Seek Proposals For Less Invasive Detection, Diagnosis, Treatment Technologies

July 3, 1998

Continuing Resolution Expires March 27; NIH, NCI Hope For Budget Compromise

March 15, 2013